Abstract At the heart of the development of fertilized eggs into fully formed organisms and the adaptation of cells to changed conditions are genetic regulatory networks (GRNs). In higher multicellular organisms, signal selection and multiplexing are performed at the cis-regulatory domains of genes, where combinations of transcription factors (TFs) regulate the rates at which the genes are transcribed into mRNA. To be able to act as activators or repressors of gene transcription, TFs must first bind to target sequences on the regulatory domains. Two TFs that act in concert may bind entirely independently of each other, but more often binding of the first one will alter the affinity of the other for its binding site. This article presents a systematic investigation into the effect of TF binding dependences on the predicted regulatory function of this bio-logic. Four extreme scenarios, commonly used to classify enzyme activation and inhibition patterns, for the binding of two TFs were explored: independent (the TFs bind without affecting each other's affinities), competitive (the TFs compete for the same binding site), ordered (the TFs bind in a compulsory order), and joint binding (the TFs either bind as a preformed complex, or binding of one is virtually impossible in the absence of the other). The conclusions are: (1) the laws of combinatorial logic hold only for systems with independently binding TFs; (2) systems formed according to the other scenarios can mimic the functions of their Boolean logical counterparts, but cannot be combined or decomposed in the same way; and (3) the continuously scaled output of systems consisting of competitively binding activators and repressors can be controlled more robustly than that of single TF or (quasi-)logical multi-TF systems.
Introduction
Apart from blueprints for proteins -their so-called code -many genes also carry information that ultimately directs where, when, and to what extent they will be expressed. A gene is said to be expressed when, at a particular time in a particular cell, transcripts of its code are detectably present. Because these transcripts are, in general, short-lived, the fact that they can be detected indicates that the gene is currently being transcribed, and suggests that the transcripts are also being translated into protein.
Central to the control of gene expression is the interaction of so-called trans-regulatory factors with noncoding, regulatory domains of genes (see, e.g., [7, 11] for recent reviews). The group of characteristics of transcriptional regulation -the way in which TFs combine to generate a certain effect -but to set the scene we first give a brief overview of the most important dynamic aspects of GRNs.
The diagram in Figure 1 shows the basic participants and processes in the expression of one gene, gX. Circles stand for molecular species; rectangles stand for processes. Closed arrowheads starting or ending at a vertical edge of a process rectangle indicate the production or consumption of material by the process; open arrows that end on a horizontal edge of a process rectangle denote a regulatory interaction. The molecular species that function as regulators modify the rate of a particular process, but are not themselves consumed in that process. The transcription of gene gX is regulated by a number of transcription factors, whose interaction and effect we will concentrate on in the sections following this one. The transcription product is messenger RNA mX, which in turn functions as a regulator in its own translation. The translation product is the protein pX, which may function as a TF in the transcription of other genes. In this example, pX does not affect the rate of transcription of its ''own'' gene (gene X), but in reality many TFs do, directly or via longer feedback loops. Apart from genes, which, in this model, live forever, all other molecular species have finite lifetimes.
Technically, the transcription and translation processes consume material as well: the building blocks of RNA (nucleotides) and proteins (amino acids), and energy carriers (such as ATP). They also produce more than only mRNA and protein molecules (namely ''waste,'' such as pyrophosphate, water, and heat), but the building blocks are regenerated from the decay products, and the waste is reused or otherwise dealt with, and we shall assume that their overall effect is constant.
When gX is switched from off to on, for instance as a result of the reception of a specific signal at the cell surface, production of mX will start. Because mX molecules have a finite lifetime, t mX , they will disappear after some time. Some time after the activation of gX, the system will reach a steady state, in which the number of mX molecules that are produced per unit of time equals the number of molecules that disappear. The steady state concentration of mX (number of molecules per unit of volume) will remain constant until the production or breakdown rates change, and the steady state concentration of mX, [mX] ss , is equal to v x t mX , where v x is the transcription rate of gene gX (concentration is the number of molecules or moles per unit of volume, and is conventionally indicated by square brackets). Similarly, [pX] The product of the transcription of a gene (here gX) is a specific type of mRNA (mX), and the product of mX translation is the protein pX. The rate at which the gene is transcribed is regulated by so-called transcription factors (TFs). The transcription of a single gene may be controlled by many TFs, acting alone or in combination. TFs are proteins themselves, and are therefore produced in a translation process. Apart from the gene itself, all participants have a limited life span, and disappear as a result of specific decomposition processes.
It is useful to be aware of the following.
1. In simple irreversible production-decay sequences such as those in Figure 1 , the transient time (the time required to reach a new steady state) depends only on the lifetimes of the species, not on their production rate. Typically, mRNA molecules live for at least a few hours, so that expression levels are not expected to stabilize for several hours after a change in the transcription rate has occurred.
2. Transcription and translation, mRNA and protein breakdown, and, in eukaryotes, transport and modification of the transcripts are complex multi-step processes, and their dynamics may be more accurately described by delay functions than by the type of equations used here and in most other studies.
3. The functionality of mRNA and proteins can be changed rapidly in specific post-transcriptional and post-translational processes. Rapid changes in the functionality of certain gene products may be coupled to much slower changes in gene expression levels.
4. Feedback loops are a prominent feature of all but the simplest GRNs (cf. [2, 6, 19] ), and their presence, particularly in combination with delays, can give rise to much more complex behavior-oscillatory, switchlike, or even chaotic-than the simple linear dynamics described above.
Transcription Factor Binding
From here on, we shall concentrate on the interactions of the TFs and the cis-regulatory domain of the gene and their regulatory effect. As stated above, TFs must be bound-directly, or via other TFs -to the gene's regulatory domain to exert their effect on transcription initiation. Firstly we explain the basic thermodynamics of complex formation; more comprehensive treatments may be found in physical chemistry or enzyme kinetics textbooks. 
is a reciprocal measure for A's affinity for D. A smaller value indicates a higher affinity, and the higher a molecule's affinity for another, the more time they will on average spend as a complex. K relates to the Gibbs free energy (DG) of complex formation as
where R is the universal gas constant, and T the absolute temperature. Equilibrium constants are determined by the nature of the complexes (and by external factors such as temperature, pH, ionic strength, etc., which we shall assume to be constant), but not by the total concentrations of their constituents.
If 
Here a is the normalized concentration of A (normalized to the equilibrium dissociation constant for the complex AD, a ¼ A T /K DA ), and a is the fractional saturation of the binding site for A. If we further assume that averages over a sufficiently long period of time are equal to averages over many molecules (ergodicity), the fractional saturation is equal to the fraction of time A spends as a part of the complex AD, and the fraction of time that A is not bound is equal to 1 À a.
Binding of Two TFs
If another TF, B, also binds to D, five more association reactions must be considered: D + B W DB, DA + B W DAB; DB + A W DAB, A + B W AB, and D + AB W DAB (we disregard further isomerization reactions such as DNA looping). First, we consider the case in which A and B have an infinitely small tendency to form a complex in solution, away from D (so that the last two reactions in the above list do not occur). We denote the equilibrium dissociation constant for DB as
s total concentration as B T , and, assuming that
Furthermore, we need to take into account that the equilibrium dissociation constant for
, is not necessarily equal to K DB , and we use the symbol r to indicate the ratio K DB /K DBA (which must be equal to K DA /K DAB , where
DAB]). A value of r that is different from 1 indicates a dependence in the binding of A and B to D:
If r > 1, the presence of bound A stimulates the binding of B; if r < 1, bound A inhibits the binding of B to a certain extent. The fractional saturation a of the binding site for A is now equal to the fraction of time that the complex spends as DA or DAB, and the same holds for h, the fractional saturation of the binding site for B:
In Table 1 , we have listed the expressions for a and h for the extreme cases in which A and B bind independently (r ¼ 1), competitively (r ¼ 0), in compulsory order (K B ! l, with b redefined as B T /K DBA ), and in a highly dependent way (coincident ), where A has virtually no affinity for the target in the absence of B, and vice versa (K A , K B ! l; a and b redefined as A T /K DAB and B T /K DBA ). Also listed are the expressions for the fraction of time that neither A nor B is bound (B D ); A but not B, and B but not A (B DA and B DB ); and both A and B simultaneously (B DAB ).
In scenario 1, in which the TFs bind independently, the fraction of time that, for example, only A and not B is bound is calculated by multiplying the probability that A is found bound to the cisregulatory domain (i.e., a) with the fraction of time that B is not bound (1Àh). The expressions for B are readily generalized to n independently binding TFs. In scenario 4 ( joint binding), the TFs act as if they were a single entity, and may function as such in the generalized expressions for scenario 1. However, these simple relationships do not hold in scenarios 2 and 3, and the fraction of time that, for instance, DA exists (B DA ) is also dependent on the amount of B present.
If it is taken into account that A and B may form a complex away from, as well as on, D, then the general expressions for a and h become even more complex. However, in the extreme case that the equilibrium dissociation constant for the preformed complex AB, K AB , is very small, the expressions can be significantly simplified. Under these conditions A and B form a very strong complex, and only ever bind to D as the complex AB, not separately, and therefore they act essentially as a single species. In that case, here listed as scenario 5, the total amount of preformed AB is expressed as min(A T , B T ), and the normalized concentrations a and b are both redefined as min(A T , B T )/K DAB , where K DAB is the equilibrium dissociation constant associated with the reaction AB + D W DAB.
Binding of TFs of the Same Type
If A and B are equal, the equations of Table 1 1 + a) again. These equations are easily generalized to n molecules of A, where n indicates the multiplicity. The equation B DAn ¼ a n /(1 + a n ) is often used to generate sigmoid dependences, particularly when some kind of threshold function is required to defend a particular point of view. The exponent n, which determines the steepness of the function, is often referred to as the Hill coefficient. It is useful to be aware of the fact that using the value of n implies that an n + 1-body collision (between n TFs and one target; hence the term coincident binding) is required to form the complex. If the TFs bind as a preformed homo-oligomer, the multiplicity, and therefore the Hill coefficient, is one. 
Binding of Multiple TFs
The expressions for a and h in Equation 2 are readily generalized to more than two different TFs. Binding of each individual TF potentially affects the affinity of all others, and it will be necessary to define equilibrium constant ratios for all potential complexes. The expressions in the five scenarios may be expanded and combined, but in the following we shall focus on situations in which no more than two TFs are involved in the stimulation or repression of gene expression.
Regulation of Gene Expression
Above we have described and classified the various ways in which TFs interact with their binding sites and each other to form particular complexes, and how the fraction of time that each of the complexes exists depends on the concentrations of the individual TFs. In this section, we discuss how the observation that a TF, or a combination of TFs, acts to stimulate or repress gene transcription could relate to these binding patterns.
Little is known about the precise way in which TF combinations influence the gene transcription rate, and here we will take for granted that some stimulate it and others repress it. There is no rule that tells how the fractional saturation B DX for a complex DX relates to transcription rate. For practical purposes it is usually assumed that the transcription rate is simply proportional to fractional saturation, and this approach was first used to account quantitatively for the observed control of gene expression by the bacteriophage E repressor ( [1, 16] ; see also [2] and references therein). Although this assumption has -often tacitly -been made in many later studies, we would like to point out that there is, in fact, little evidence that it is entirely justified in more complex eukaryotic regulatory systems.
Quite independently of the precise relationship between TF binding and transcription rate, we argue that the number of output combinations that can be addressed is restricted by the binding scenario. In the following, we shall assume that there is a certain maximum rate, V max , at which gene transcription can be initiated (which is, among other factors, determined by the size of the RNA polymerase that carries out the transcription, and by the speed at which it vacates its assembly site). We define a pure activator as a TF that, when present in sufficient quantities to achieve maximal saturation of its binding site (according to Table 1), is able to raise the transcription rate r ini (and with it the expression level), from 0 to the maximum possible value V max . A pure repressor is a TF that will decrease a gene's expression level from the maximum to 0 when its binding site is fully saturated. Pure activators and repressors do not necessarily achieve their effect by themselves: They may do so only in combination with other TFs.
All-or-None Stimulation or Repression of Gene Expression
Firstly, we shall consider all-or-none situations, in which TFs are present in such quantities that their binding sites are fully saturated. In Figure 2 , we have listed the output patterns that can be achieved by combinations of two TFs, each of which is a pure activator or pure repressor, for the independent, competitive, ordered, and joint (coincident, and as a complex) binding scenarios. Activators or repressors may achieve their effect alone (disjunctively) or in combination with other activators or repressors (conjunctively). A gene that needs activation is expressed only when the activator is present, whereas a gene that is regulated by repression is expressed when the repressor is absent.
The symbols in Figure 2 Each input pattern (00: both TFs absent; 10: A present, B absent; 01: A absent, B present; 11: both present) will result in a particular output pattern (0: gene not expressed, 1: gene expressed), and the output patterns for eight configurations, together with their Boolean logic formulation, are listed underneath the diagrams that represent the configurations in which the TFs bind independently. Configurations in the same box have the same output pattern. For TFs that bind independently, it is necessary to specify whether they act alone (disjunctively) or together (conjunctively); in the other cases the action of combinations of activators and inhibitors is determined by their binding mode.
Thus, the third row of symbols in Figure 2 , for example, symbolizes the configurations in which A is a repressor and B is an activator. If A and B bind independently and act alone (first column), the gene will be transcribed (output 1) either when A is absent or when B is present (even if A is there as well). The gene is repressed (output 0) only when A is present (1) and B is not (0). The output pattern is therefore 1011 for inputs 00, 10, 01, 11. (Formally, the absence of a repressor that is observed to work alone is sufficient to allow the gene to be transcribed.) A similar behavior is predicted to be generated by two TFs that bind in compulsory order, if the one that binds first, A, is a repressor, and B, the one that binds only when A is already bound, is observed to be an activator (and is indicated as such in the diagram, but is in fact an inhibitor of the repressive action of A). Therefore, A will repress gene expression by itself, but loses its repressive power when B is present. Therefore, the output pattern is for this configuration is 1011 as well.
If A and B bind independently, but act in conjunction (column 5), the gene will be transcribed only when B is present but A is not (output pattern 0010). This illustrates the fact that the absence of a repressor that works in conjunction is formally insufficient to activate a gene. In column 7, where A and B bind in compulsory order, with B as the primary activator, A inhibits the activating capability of B, so that the gene is expressed only when B is present and A is absent, and the output pattern is again 0010.
If two competitively binding TFs are both activators (as in row 1, column 2), the gene will be activated unless neither is present, and if both are repressors (row 4, column 6), the gene will be activated only when neither is present. However, in the case in which one is an activator and the other is a repressor (rows 2 and 3, columns 2 and 6), it is not possible to decide whether the TFs act alone or together and resolve the output pattern without further information on the relative amounts of the TFs. The two configurations that give rise to this type of logic (rows 2 and 3) are depicted in gray, and situated in the appropriate columns (2 and 6). Figure 3 shows that the fractional saturation for the 0100 (A and not B, Figure 2 , row 2, column 5) output pattern is almost indistinguishable from that of an activator and repressor that bind in compulsory order (row 2, column 7). Apart from the scenarios in which an activator competes with a repressor (see below), this is true for all output patterns within the same group listed in Figure 2 , and it would be tempting to suppose that combinations within a group are fully equivalent (cf., e.g., [9] ). Table 1 ); row 2: an activator and repressor that bind in compulsory order (a/(1 + a + ab)); row 3: an activator and repressor that compete for a binding site (a/ (1 + a + b) ). Column 1 (left) indicates the symbols for the three combinations, and columns 2 and 3 show the values of r ini /V max at low (0 V a, b V 1, column 2) and high (0 V a, b V 1000, column 3) normalized concentrations.
The Logic of Gene Expression
However, the essence of combinatorial (Boolean) logic is formulated in De Morgan's theorems: NOT A AND NOT B is equivalent to NOT (A OR B), and NOT A OR NOT B is equivalent to NOT (A AND B) . Inspection of Table 1 in combination with Figure 2 shows that the above theorems hold for independently binding TFs, but not for any of the other modes. For example: for independently binding TFs, NOT A AND NOT B, (1 À a)(1 À h), can be rewritten as 1 À (a + h (1 À a) ), which is equivalent to NOT (A OR B). However, NOT (A OR B) translates into 1 À a À h when the TFs bind in competitive fashion, which is evidently not equal to NOT A AND NOT B, which for this scenario also translates as (1 À a)(1 À h) . Furthermore, NOT A OR NOT B, (1 À a) + (1 À h) À (1 À a)(1 À h) , for independently binding TFs is rewritten as 1 À ah, that is, NOT (A AND B) , whereas for repressors that bind in compulsory order NOT (A AND B) translates into 1 À h, and is therefore equivalent to NOT B. Thus, the rules that hold for Boolean logic can be applied to independently binding TFs, but cannot be applied in their entirety to TFs that bind according to the other scenarios. In bio-logic, the logic of gene expression, the configurations listed in columns 2 -4 and 6 -8 must be considered as distinct non-Boolean operators.
Addressing Intermediate Expression Levels
In general, the saturation level of the binding site for a particular TF (see Table 1 ) is a hyperbolic or sigmoidal function of TF concentration. If its concentration in a particular cell is in the vicinity of its equilibrium constant, its binding site will not be occupied full time. If the level of activation or repression of transcription initiation is proportional to the average fraction of time that some activating or repressing complex exists, the expression level may be regulated by varying the concentration of TFs. However, this process is likely to have a limited dynamic range, for one or more of the following reasons:
1. If a TF has a high affinity for its binding site, a few molecules may already be sufficient to fully saturate the binding site.
2. If the saturation curve is sigmoidal, expression levels may change quite dramatically as a result of a relatively small change in TF concentration.
3. The relationship between fractional saturation and modifier effect is, as pointed out above, likely to be nonlinear, and full activity may be achieved well before the binding site is fully saturated.
Therefore, variation of absolute TF concentrations is probably unsuitable as a robust general mechanism for fine tuning of gene expression levels. Figure 3 shows that intermediate output values are addressed over a relatively narrow normalized concentration range (a and b) for an activatorrepressor pair that bind independently and act conjunctively, or bind in compulsory order (activator first). For both, the repressor dominates when a and b are both high. However, expression levels can be regulated in a potentially much more precise and robust way by varying the concentrations of two TFs with opposite effects that compete for a single binding site on the cis-regulatory domain. In that case (Figure 3, bottom row) , intermediate values can be addressed by varying the ratio of a and b, a quantity that is more readily maintained, stabilized, and controlled (for instance by reversible modification) than absolute concentrations.
Truth Tables
Activation and repression do not have to be extreme: Each combination of bound TFs may modulate the rate of transcription initiation to a certain extent. To express this, we assign a modulation coefficient, q 0 , q A , q B , or q AB , to each of the states D, DA, DB, and DAB. The value of a modulation coefficient is determined solely by the nature of the complex with which it is associated, not by the fraction of time that the complex is present. We assume that the number of times gene transcription is initiated by a particular complex is proportional to the fraction of time that particular complex exists, and that the average initiation rate, r ini , is proportional to the sum of the rates of the individual contributions:
Even though the use of Boolean logical operators to describe the combined effect of multiple TFs on gene transcription is not always appropriate, their action is probably captured most efficiently in truth tables. In these, the input is formed by the normalized concentration of all TFs that interact with the regulatory site of the gene for which the table has been set up, and the output value is calculated by applying Equation 3 as appropriate for the binding mode (generalized to the total number of TFs involved). Table 2 shows the truth tables for scenarios 1 -4.
Discussion
There is an obvious similarity between the regulatory elements of genes and logic gates: Two TFs may stimulate the expression of a gene only when both are present -in which case it is tempting to describe their interaction as logical conjunction (AND). Some TFs may appear to act irrespective of the presence of others (disjunctively as logical OR), and some clearly function to stop or repress gene expression (negation, or logical NOT ). Several earlier studies have categorized particular observed cisregulatory functions as Boolean logic operations [4, 5, 9] , but in this article we have approached the subject from the opposite direction. Rather than classifying observed behavior, we have explored all four extreme binding scenarios for two TFs, either one an activator or a repressor (with the binding scenario reflected in the denominators, and functionality in the numerators for a and h in Table 1) , and found the following. 3. Two TFs that bind in compulsory order can mimic the behavior of all combinations of independently binding activators and inhibitors. To predict the output pattern of two TFs that bind independently, it is necessary to know whether they act alone or in conjunction (Figure 2 , left and right panels). Two TFs that bind in compulsory order always act together, but to predict their output pattern, it is necessary to know which one is the primary actor.
4. The situation in which an activator and a repressor compete for the same binding site produces a non-Boolean continuous logical aspect: The output cannot be predicted without knowing the relative normalized concentrations of activator and repressor. This scenario, which is probably the most interesting from an engineering point of view, provides the system with the capability of robustly and precisely addressing intermediate expression levels, simply by varying the ratio of two TFs that have different effects (namely repression and activation). The competing TFs need not be the products of different genes: One can be a post-translationally modified version (e.g., phosphorylated), and such modification and its reversal may even occur while the TF is bound to its target site.
If the combined effect of two TFs is larger than the sum of their individual effects, the TFs are said to act in synergy. Synergy may be observed when binding of one TF strengthens the binding of the other, so that there is more of the fully formed complex than could be expected on the basis of the equilibrium dissociation constants of the individual TFs. It could also simply be observed when the fully formed complex initiates transcription more efficiently than any of the other complexes. In practice it may be almost impossible to distinguish between, or establish the relative contributions of, these two mechanisms. If two TFs have similar effects, but act in different developmental stages or in different types of tissue, they probably bind and act truly independently. Their binding sites are likely to be part of different cis-regulatory modules [3] , and the use of the true logical OR operator to describe their combined effect is almost certainly justified.
